Tryptophan availability, central serotonergic function and methionine sulphoximine-induced convulsions

Area of Science:

• Neuroscience
• Biochemistry
• Pharmacology

Background:

• Serotonin (5-hydroxytryptamine, 5-HT) is a key neurotransmitter involved in various physiological processes.
• Tryptophan (TRY) is the essential amino acid precursor for serotonin synthesis.
• Methionine sulfoximine (MSO) is known to induce seizures and affect amino acid metabolism.

Purpose of the Study:

• To investigate the effect of MSO on central serotonin levels and tryptophan availability in mice.
• To determine the relationship between MSO-induced changes in tryptophan and serotonin synthesis.
• To explore the role of the serotonin system in modulating MSO-induced seizures.

Main Methods:

• Administration of convulsant (100 mg/kg) and subconvulsant (50 mg/kg) doses of MSO to C57BL/6J mice.
• Measurement of central 5-HT, plasma, and brain tryptophan concentrations at various time points.
• Administration of l-tryptophan concurrently with MSO to assess its effect on seizure latency.

Main Results:

• A convulsant MSO dose significantly decreased central 5-HT and both plasma and brain tryptophan levels.
• A subconvulsant MSO dose did not affect central 5-HT but transiently reduced brain tryptophan.
• Co-administration of l-tryptophan with MSO dose-dependently increased seizure latency.

Conclusions:

• Convulsant MSO administration impairs serotonin synthesis by restricting tryptophan availability.
• The central serotonin system appears to play a modulatory role in the expression of MSO-induced seizures.
• Tryptophan availability is a critical factor influencing MSO neurotoxicity and seizure induction.